Dorsey Wright & Associates’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,025
Closed -$1.43M 153
2026
Q1
$1.43M Buy
+3,025
New +$1.52M 0.18% 107
2023
Q3
Sell
-5,871
Closed -$1.78M 299
2023
Q2
$1.78M Buy
+5,871
New +$1.63M 0.54% 91
2022
Q2
$243K Hold
1,447
0.07% 106
2022
Q1
$363K Buy
1,447
+213
+17% +$53.5K 0.08% 113
2021
Q4
$317K Sell
1,234
-218
-15% -$53.3K 0.07% 115
2021
Q3
$352K Buy
+1,452
New +$355K 0.08% 117
2019
Q2
Sell
-11,460
Closed -$1.49M 304
2019
Q1
$1.49M Buy
+11,460
New +$1.54M 0.36% 109

Other funds holding HCA

Dorsey Wright & Associates's HCA Position: Q2 2026 in Review

Dorsey Wright & Associates sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 3,025 shares — an estimated $1.43M sold.

Dorsey Wright & Associates first reported a position in HCA in Q1 2019 and held it in 7 quarters. The position peaked at $1.78M in Q2 2023. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Dorsey Wright & Associates reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Dorsey Wright & Associates sold 3,025 HCA Healthcare shares in Q2 2026, an estimated $1.43M.
  • Dorsey Wright & Associates first reported a position in HCA Healthcare in Q1 2019 and held it in 7 quarters.
  • Dorsey Wright & Associates's HCA Healthcare position peaked at $1.78M in Q2 2023.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.